|1.||Tuberous Sclerosis (Bourneville's Disease)
|5.||Astrocytoma (Pilocytic Astrocytoma)
|1.||Moss, Joel: 16 articles (03/2015 - 12/2004)|
|2.||Kwiatkowski, David J: 7 articles (12/2015 - 10/2002)|
|3.||Pacheco-Rodriguez, Gustavo: 7 articles (03/2015 - 12/2004)|
|4.||Johnson, Simon R: 7 articles (01/2014 - 04/2002)|
|5.||Gorio, Alfredo: 7 articles (05/2013 - 10/2005)|
|6.||Lesma, Elena: 7 articles (05/2013 - 10/2005)|
|7.||Di Giulio, Anna Maria: 6 articles (05/2013 - 10/2005)|
|8.||Henske, Elizabeth Petri: 6 articles (02/2010 - 02/2003)|
|9.||Taveira-DaSilva, Angelo M: 5 articles (01/2015 - 12/2005)|
|10.||Bissler, John J: 5 articles (09/2014 - 01/2008)|
|1.||Sirolimus (Rapamycin)FDA Link
09/01/2013 - "Although the mammalian target of rapamycin inhibitor seems to be effective for treating epithelioid angiomyolipoma, its long-term effects remain unknown. "
11/01/2014 - "This study shows that renal angiomyolipoma shrank during sirolimus therapy but tended to regrow after the therapy was stopped. "
11/01/2014 - "Studies that reported an angiomyolipoma response or adverse events after the treatment of sirolimus were included in the analysis. "
09/01/2011 - "In two studies, angiomyolipoma size decreased by 26-50% after 12 months of sirolimus treatment. "
06/15/2011 - "This study investigated the efficacy and safety of the mTORC1 inhibitor sirolimus for treatment of renal angiomyolipomas in patients with these disorders. "
09/01/2015 - "Everolimus was very effective in the treatment of Anne, a patient with TSC and renal angiomyolipomas. "
12/01/2015 - "These observations confirm the strong association between TSC2 mutation and angiomyolipoma burden seen in previous studies, and they indicate that everolimus response occurs regardless of mutation type or location or when no mutation in TSC1 or TSC2 has been identified. "
12/01/2015 - "Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2."
06/01/2014 - "Everolimus showed efficacy in reducing angiomyolipoma lesion volume in patients with SEGA associated with TSC.The"
06/01/2014 - "Greater percentages of everolimus-treated patients had angiomyolipoma reductions ≥30% at these same time points (82.6, 100 and 100% versus 8.3, 18.2 and 16.7% for everolimus versus placebo, respectively). "
05/23/2000 - "In this study, we report the identification of somatic TSC2 mutations in five of seven angiomyolipomas from sporadic LAM patients. "
12/01/2015 - "Definite (vs suspected) TSC diagnosis, CKD stage 5 (vs CKD stage 1), angiomyolipoma size ≥3.5 cm, and moderate or severe LAM were associated with higher costs (p = 0.050 for TSC diagnosis, p ≤ 0.002 for other comparisons). "
01/01/2014 - "Patients with LAM have a high prevalence of symptomatic angiomyolipoma which can present at any time. "
01/01/2014 - "In patients with sporadic LAM presentation of angiomyolipoma preceded or followed onset of lung symptoms by up to 11 and 38 years respectively. "
01/01/2014 - "One hundred and seven had sporadic LAM, of which 53 (50%) had at least one angiomyolipoma. "
|4.||Clear-cell metastatic renal cell carcinomaIBA
06/01/2013 - "Median chemical shift index was significantly greater in clear cell RCC and angiomyolipoma than in the other histological subtypes (both, P < 0.001). "
01/01/2016 - "Establishment of threshold enhancement values helped to differentiate clear cell RCC from papillary RCC, chromophobe RCC, and fat-poor angiomyolipoma with the following accuracies: percentage enhancement ratio, 84.7% (399/471) for papillary RCC, 71.1% (325/457) for chromophobe RCC, and 81.9% (377/460) for fat-poor angiomyolipoma; enhancement change, 80.9% (381/471) for papillary RCC, 70.2% (321/457) for chromophobe RCC, and 80.6% (371/460) for fat-poor angiomyolipoma; absolute washout ratio, 88.5% (417/471) for papillary RCC, 74.1% (339/457) for chromophobe RCC, and 85.0% (391/460) for fat-poor angiomyolipoma. "
01/01/2016 - "Quantitative enhancement measurement may be useful for differentiating clear cell RCC from papillary RCC, chromophobe RCC, and fat-poor angiomyolipoma."
12/01/2014 - "Mean attenuation of minimal-fat angiomyolipoma was 43.1±9.8 HU, which was significantly higher when compared with RCC overall (p=0.004) as well as with clear cell RCC (33.1±10.2 HU; p=0.003), papillary RCC (33.0±6.6 HU; p=0.003), and chromophobe RCC (34.3±9.9 HU; p=0.01). "
11/01/2014 - "Four-phase MDCT renal attenuation profiles enable differentiation of clear cell RCC from other solid renal cortical masses, most notably papillary RCC and lipid-poor angiomyolipoma."
|5.||Ethanol (Ethyl Alcohol)IBA
10/01/2014 - "Transcatheter arterial embolization (TAE) with absolute ethanol is widely accepted as a therapeutic procedure for renal angiomyolipoma (AML). "
10/01/2014 - "Evaluation of split renal function before and after renal arterial embolization for angiomyolipoma using absolute ethanol."
10/01/2009 - "We evaluated the efficacy and side effects of transarterial ethanol ablation in sporadic and non-hemorrhaging angiomyolipomas (AMLs) in the kidney. "
10/01/2009 - "Transarterial ethanol ablation for sporadic and non-hemorrhaging angiomyolipoma in the kidney."
09/01/2008 - "We describe a case of a sporadic asymptomatic angiomyolipoma treated with absolute alcohol embolization."
06/01/2008 - "This is to our knowledge the first report in which tamoxifen has been successfully used in a TSC patient with multiple liver angiomyolipomas."
04/01/2004 - "Tamoxifen citrate also stimulated cell growth, associated with increased phosphorylation of p44/42 MAPK and expression of c-myc, indicating that tamoxifen has agonist effects on angiomyolipoma cells. "
06/01/2008 - "Massive hepatic angiomyolipoma in a young woman with tuberous sclerosis complex: significant clinical improvement during tamoxifen treatment."
04/01/2004 - "Our data provide the first evidence that estradiol stimulates the growth of angiomyolipoma cells, that tamoxifen has agonist effects in angiomyolipoma cells, and that estradiol and tamoxifen impact both genomic and nongenomic signaling pathways in angiomyolipoma cells. "
04/01/2004 - "This response to tamoxifen in human angiomyolipoma cells differs from prior studies of Eker rat leiomyoma cells, possibly reflecting cell type or species differences in cells lacking tuberin. "
02/01/2014 - "We identified 147 patients with pathologically proven elements of renal oncocytoma (96), angiomyolipoma (44) or another solid benign pathology (7). "
02/01/2014 - "Lesions containing elements of renal oncocytoma, angiomyolipoma or another benign pathology formed the basis for this analysis. "
08/01/2013 - "For benignancy, 13 angiomyolipoma showed contrast agent slow wash-in and slow wash-out mode, while 2 renal oncocytoma showed similar enhancement characteristic to the malignant lesions. "
01/01/2009 - "Unilateral simultaneous renal oncocytoma and angiomyolipoma: case report."
07/01/2003 - "We describe a case of oncocytic angiomyolipoma composed of polygonal eosinophilic cells, that shares many features with renal oncocytoma. "
|8.||glucuronyl glucosamine glycan sulfate (Vessel)IBA
10/01/2005 - "This reliably identified the efferent vessel of the hepatic angiomyolipoma to be the hepatic vein in both cases, which corresponded well with that seen on conventional angiography and CT angiography. "
10/01/2005 - "Hepatic angiomyolipoma: identification of an efferent vessel to be hepatic vein by contrast-enhanced harmonic ultrasound."
02/01/2003 - "We found that angiomyolipomas contain five morphologically distinct vessel types: cellular, collagenous, hemangiopericytic, glomeruloid, and aneurysmatic. "
09/01/2012 - "In the treatment of hemorrhagic complications of angiomyolipoma, a surgical treatment (partial or radical nephrectomy) or renal vessel embolization is used. "
07/01/2009 - "We report a case of giant angiomyolipoma with a dilated vessel susceptible to hemorrhage."
09/01/2004 - "The typical immunophenotype of all types of angiomyolipoma (cytokeratin-negative and melanomarkers-positive) is very useful in diagnosis but does not help in the differentiation from renal adenocarcinoma at frozen section. "
05/01/2008 - "After several tumorectomies, the suspicious mass, 4 cm in size, was diagnosed as epithelioid angiomyolipoma, with immunohistochemical confirmation of capacity for HMB45, and negative vimentin and keratin. "
06/01/2008 - "Despite the morphologic resemblance of this tumour to renal cell carcinoma, its phenotype (HMB45, Melan A and CD68 positivity and keratin negativity) parallels the phenotypic profile of angiomyolipoma. "
06/01/1998 - "Despite the marked morphologic resemblance of these tumors to high-grade sarcomatoid renal cell carcinoma, their phenotype (HMB45+, CD68+/-, actin+/-, and vimentin and keratin negative) is in contrast to that observed in epithelial tumors and parallels the phenotypic profile of angiomyolipoma. "
10/01/1997 - "In both, the tumor cells lacked keratin expression and were positive for vimentin and HMB 45, an antibody recognizing perivascular or myoid cell proliferation such as lymphangioleiomyomatosis and angiomyolipoma. "
|10.||Ethiodized Oil (Ethiodol)FDA Link
08/01/2014 - "Embolization with a mixture of lipiodol and PVA particles is an effective and safe treatment for symptomatic renal angiomyolipoma. "
08/01/2014 - "Seven patients underwent eight episodes of embolization using a mixture of lipiodol and PVA particles to treat symptomatic renal angiomyolipoma. "
08/01/2014 - "We performed a retrospective review of the seven patients who underwent embolization with a mixture of lipiodol and PVA particles to treat symptomatic renal angiomyolipoma in our center between February 2011 and December 2013. "
08/01/2014 - "Embolization of symptomatic renal angiomyolipoma with a mixture of lipiodol and PVA, a mid-term result."
08/01/2014 - "To evaluate the clinical effect of renal artery embolization with a mixture of lipiodol and polyvinyl alcohol (PVA) particles on symptomatic renal angiomyolipoma and to present the mid-term results from our single-center site. "
09/01/2015 - "The study included 406 patients who had 47 angiomyolipomas without visible fat and 359 RCCs smaller than 4 cm, all of which were diagnosed on the basis of findings from nephrectomy or percutaneous biopsy performed at our institution between 2000 and 2011. "
01/01/2006 - "Left radical nephrectomy was performed and the pathological study of the surgical specimen confirmed the diagnosis of angiomyolipoma. "
08/01/2015 - "Approximately 25% of patients with TSC-renal angiomyolipoma experienced embolization or nephrectomy, with some patients undergoing repeat procedures. "
01/01/2015 - "We present the treatment of lower pole stones of a 62-year-old male patient with a history of open partial nephrectomy due to renal angiomyolipoma and renal stones. "
01/01/2015 - "We present a patient with a spontaneously ruptured kidney due to a central renal angiomyolipoma, which was treated by laparoscopic nephrectomy. "
07/01/1989 - "Moreover, therapeutic embolization for angiomyolipoma was concluded to be very useful."
10/01/2002 - "We identified 13 series published since 1986 comprising 336 patients as well as 24 reports of therapeutic embolization for angiomyolipoma, comprising 76 patients. "
07/01/1989 - "[Therapeutic embolization of renal angiomyolipoma: a case report]."
11/01/1987 - "This case and others encountered in our review of the literature underscore the usefulness of therapeutic embolization for renal angiomyolipoma."
11/01/1987 - "Therapeutic embolization for renal angiomyolipoma: case report and review of the literature."
12/01/2012 - "Recently, regression of angiomyolipoma size has also been achieved with mTOR inhibitor therapy, but recurrent lesion growth after treatment cessation has to be expected. "
06/01/2011 - "Development of hepatic angiomyolipoma accompanied with focal nodular hyperplasia long after treatment of pelvic rhabdomyosarcoma."
09/01/2011 - "The protective effect of sirolimus was lost after treatment discontinuation, with a parallel lung function decline in both groups, similar to the increase in angiomyolipoma size. "
12/01/2012 - "Reduction in size of renal angiomyolipoma after treatment with everolimus in lung transplantation due to lymphangioleiomyomatosis."
05/01/2015 - "After treatment with sirolimus for 12 months, one patient presented resolution of severe chylothorax; one had a significant reduction in renal angiomyolipoma volume; and one showed significant regression of retroperitoneal lymphangioleiomyomas and abdominal lymph node enlargement. "
02/01/2003 - "Bench-top fine-needle aspiration biopsy (FNAB) following splenectomy and nephrectomy from a 21-yr-old female of tuberous sclerosis with right renal angiomyolipoma and splenic hamartoma was performed for the correlation of the cytologic features with histologic findings and, along with the immunopathologic studies, for the establishment of a challenging preoperative diagnosis of splenic hamartoma. "
06/01/2013 - "A 55-year-old man with a history of chronic hepatitis B infection and alcoholism had undergone previously a left lateral segmentectomy for hepatic epitheloid angiomyolipoma (4.6 × 3.5 × 3.3 cm) with a concomitant splenectomy. "